Biologic drug delivery faces hurdles with injection-based methods. New advancements in inhaled and oral delivery show promise for improving patient compliance.
The SoLV method incorporates real-world data on health disparities and offers a more equitable way to assess drug value, moving beyond the limitations of QALYs.
Lonza is advancing drug development with AI route scouting, reducing costs and optimizing synthetic routes in record time, helping companies submit INDs faster.
AI is reshaping drug discovery, clinical trials, and manufacturing in the pharma industry, reducing costs and speeding up development while enhancing precision.
AI and ML offer pharmaceutical firms data-driven insights for R&D but require overcoming challenges in data integration and quality aided by ACD-Labs solutions.
